Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01852747 · ClinicalTrials.gov registry record · Phase 4
Comparison of Actifuse ABX and Local Bone in Spinal Surgery
A Phase 4 study, sponsored by Ohio State University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 14
- Enrollment target
NCT01852747 is a Phase 4 study that was terminated before completion, run by Ohio State University. The registered enrollment target is 14 participants.
The verdict
NCT01852747, a Phase 4 study, was terminated before completion, sponsored by Ohio State University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 14 participants
- Enrollment target
Study Summary
This study is being done to compare people who had a standard of care spinal fusion using part of their local bone graft (a small amount of bone from the region of the spine where the fusion is occurring) to correct an adult spinal deformity and people who will have a standard of care spinal fusion using a mixture of Actifuse ABX® (a market approved bone graft substitute) and a local bone graft (a small amount of bone from the region of the spine where the fusion is occurring). This study will compare the outcomes of both groups to help the Orthopaedic surgeon conducting spinal fusions in the future. Investigators expect that Actifuse ABX® will be as good if not better than just a local bone graft.
Interventions
- PROCEDURE Multilevel Spinal fusion with Actifuse ABX®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2013-03 |
| Est. Completion | 2016-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01852747
The ClinicalTrials.gov registry entry for NCT01852747 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Multilevel Spinal fusion with Actifuse ABX® is the first listed.
NCT01852747 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01852747 about?
NCT01852747 is a clinical study titled "Comparison of Actifuse ABX and Local Bone in Spinal Surgery". This study is being done to compare people who had a standard of care spinal fusion using part of their local bone graft (a small amount of bone from the region of the spine where the fusion is occurring) to correct an adult spinal deformity and people who will have a standard of care spinal fusion ...
What is the current status of trial NCT01852747?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 14 participants. The study started on 2013-03. Estimated completion is 2016-01.
What interventions are being tested in trial NCT01852747?
The interventions under investigation include: Multilevel Spinal fusion with Actifuse ABX® (PROCEDURE).
Who is sponsoring clinical trial NCT01852747?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.